Another diabetes drug scarce until end 2024

empty box
Eli Lilly’s Trulicity had been been ‘go-to’ replacement for in-demand Ozempic Trulicity, the type-2 diabetes preparation which had been a regular stop-gap option when the much-hyped Ozempic was in short supply, is now itself facing shortages until the end of 2024. The Lilly drug, with active ingredient dulaglutide, was frequently prescribed as a replacement during

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous AFT sees 24% hike in sales  
Next Remove pharmacy vax red tape in 8CPA: report